At meeting held on 20 June 2017
The Board of Directors of Fredun Pharmaceuticals at its meeting held on 20 June 2017 approved to issue compulsorily convertible preference share aggregating Rs 2.50 crore to eligible investors. The Board also considered option to purchase the three plots owned by Fredna Enterprises and the structures thereon to the Palghar Factory of the Company, which the Company is currently using as per the leave and licence agreement.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
